androstenedione has been researched along with metoclopramide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Abe, N; Kimura, K; Minakami, H; Oka, N; Tamada, T; Tamura, T | 1 |
Kimura, K; Minakami, H; Tamada, T | 1 |
3 other study(ies) available for androstenedione and metoclopramide
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prolactin release in polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androstenedione; Animals; Estrus; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Metoclopramide; Polycystic Ovary Syndrome; Prolactin; Testosterone | 1988 |
[A longitudinal study on the prognosis of ovulatory disturbance in teenage patients with high LH and normal FSH serum levels].
Topics: Adolescent; Androstenedione; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Humans; Japan; Longitudinal Studies; Luteinizing Hormone; Menstruation Disturbances; Metoclopramide; Ovulation; Polycystic Ovary Syndrome; Prognosis; Prolactin; Testosterone | 1988 |